|
1
|
Reed AL, Califano J, Cairns P, Westra WH,
Jones RM, Koch W, Ahrendt S, Eby Y, Sewell D, Nawroz H, Barterk J
and Sidransky D: High frequency of p16 (CDKN2/MTS-1/INK4A)
inactivation in head and neck squamous cell carcinoma. Cancer Res.
56:3630–3633. 1996.PubMed/NCBI
|
|
2
|
Gonzalez MV, Pello MF, Lopez-Larrea C,
Suarez C, Menendez MJ and Coto E: Deletion and methylation of the
tumor suppressor gene p16/CDKN2 in primary head and neck squamous
cell carcinoma. J Clin Pathol. 50:509–512. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Naggar AK, Lai S, Clayman G, Lee J-KJ,
Luna MA, Goepfert H and Batsakis JG: Methylation, a major mechanism
of p16/CDKN2 gene inactivation in head and neck squamous cell
carcinoma. Am J Pathol. 151:1767–1774. 1997.PubMed/NCBI
|
|
4
|
Sanchez-Cespedes M, Esteller M, Wu L,
Nawroz-Danish H, Yoo GH, Koch WM, Jen J, Herman JG and Sidransky D:
Gene promoter hypermethylation in tumors and serum of head and neck
cancer patients. Cancer Res. 60:892–895. 2000.PubMed/NCBI
|
|
5
|
Hasegawa M, Nelson HH, Peters E, Ringstrom
E, Posner M and Kelsey KT: Patterns of gene promoter methylation in
squamous cell cancer of the head and neck. Oncogene. 21:4231–4236.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weber A, Wittekind C and Tannapfel A:
Genetic and epigenetic alterations of 9p21 gene products in benign
and malignant tumors of the head and neck. Pathol Res Pract.
199:391–397. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ai L, Stephenson KK, Ling W, Zuo C,
Mukunyadzi P, Suen JY, Hanna E and Fan C-Y: The p16 (CDKN2a/INK4a)
tumor- suppressor gene in head and neck squamous cell carcinoma: a
promoter methylation and protein expression study in 100 cases. Mod
Pathol. 16:944–950. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maruya S, Issa J-PJ, Weber RS, Rosenthal
DI, Haviland JC, Lotan R and El-Naggar AK: Differential methylation
status of tumor-associated genes in head and neck squamous cell
carcinoma: incidence and potential implications. Clin Cancer Res.
10:3825–3830. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Puri SK, Si L, Fan C-Y and Hanna E:
Aberrant promoter hypermethylation of multiple genes in head and
neck squamous cell carcinoma. Am J Otolaryngol. 26:12–17. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shiga K, Matsuura K, Tateda M, Saijo S,
Ogawa T, Miyagi T and Kobayashi T: Allelic loss correlated with
tissue specificity in head and neck squamous cell carcinomas and
the clinical features of patients. Tohoku J Exp Med. 204:163–172.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shiga K, Yamamoto H and Okamoto H:
Isolation and characterization of the human homologue of rig
and its pseudogenes: The functional gene has features
characteristic of housekeeping genes. Proc Natl Acad Sci USA.
87:3594–3598. 1990.PubMed/NCBI
|
|
12
|
Shiga K, Shiga C, Sasano H, Miyazaki S,
Yamamoto T, Yamamoto M, Hayashi N, Nishihira T and Mori S:
Expression of c-erbB-2 in human esophageal carcinoma cells:
overexpression correlated with gene amplification or with GATA-3
transcription factor expression. Anticancer Res. 13:1293–1302.
1993.PubMed/NCBI
|
|
13
|
Van der Riet P, Nawroz H, Hruban RH, Corio
R, Tokino K, Koch W and Sidransky D: Frequent loss of chromosome
9p21-22 early in head and neck cancer progression. Cancer Res.
54:1156–1158. 1994.PubMed/NCBI
|
|
14
|
Zhang S-Y, Klein-Szanto AJP, Sauter ER,
Shafarenko M, Mitsunaga S, Nobori T, Carson DA, Ridge JA and
Goodrow TL: Higher frequency of alterations in the p16/CDKN2 gene
in squamous cell carcinoma cell lines than in primary tumors of the
head and neck. Cancer Res. 54:5050–5053. 1994.PubMed/NCBI
|
|
15
|
Nawroz H, van der Riet P, Hruban RH, Koch
W, Ruppert JM and Sidransky D: Allotype of head and neck squamous
cell carcinoma. Cancer Res. 54:1152–1155. 1994.PubMed/NCBI
|
|
16
|
Serrano M, Hannon GJ and Beach D: A new
regulatory motif in cell cycle control causing specific inhibition
of cyclin D/CDK4. Nature. 366:704–707. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Serrano M, Lee H-W, Chin L, Cordon-Cardo
C, Beach D and Depinho RA: Role of the INK4a locus in tumor
suppression and cell mortality. Cell. 85:27–37. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kamb A, Gruis NA, Weaver-Fejdhaus J, Lin
Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE and
Skolnick MH: A cell cycle regulator potentially involved in genesis
of many tumor types. Science. 264:436–440. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sherr CJ: Cancer cell cycles. Science.
274:1672–1677. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cairns P, Polascik TJ, Eby Y, Tokino K,
Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, et al:
Frequency of homozygous deletion at p16/CDK2 in primary human
tumors. Nat Genet. 11:210–212. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lydiatt WM, Murty VV, Davidson BJ, Xu L,
Dyomina K, Sacks PG, Schantz SP and Chaganti RS: Homozygous
deletions and loss of expression of the CDKN2 gene occur frequently
in head and neck squamous cell carcinoma cell lines but
infrequently in primary tumors. Genes Chromosomes Cancer. 13:94–98.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herman JG, Merlo A, Mao L, Lapidus RG,
Issa J-PJ, Davidson NE, Sidransky D and Baylin SB: Inactivation of
the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA
methylation in all common human cancers. Cancer Res. 55:4525–4530.
1995.PubMed/NCBI
|
|
23
|
Merlo A, Herman JG, Mao L, Lee DJ,
Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5′ CpG island
methylation is associated with transcriptional silencing of the
tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat Med.
1:686–692. 1995.
|
